Meanwhile, the S&P BSE Sensex was up 114.73 points, or 0.35%, to 32,621.45. The S&P BSE Small-Cap index was up 136.35 points, or 0.8%, to 17,232.90.

On the BSE, so far 3,785 shares were traded in the counter, compared with average daily volumes of 3,445 shares in the past one quarter. The stock had hit a high of Rs 943.05 and a low of Rs 908.90 so far during the day. The stock hit a 52-week high of Rs 1,203.30 on 12 June 2017. The stock hit a record low of Rs 650 on 24 November 2016.

The stock had outperformed the market over the past one month till 23 October 2017, rising 4.1% compared with 1.83% rise in the Sensex. The scrip, however, underperformed the market in past one quarter, falling 3.8% as against Sensex's 0.86% rise. The scrip also underperformed the market in past one year, falling 0.64% as against Sensex's 15.36% rise.

The small-cap company has equity capital of Rs 13.03 crore. Face value per share is Rs 10.

Kaya said that the company's board of directors at its meeting held yesterday, 23 October 2017 had approved investment of an amount not exceeding Rs 51 crore in KME Holdings Pte. (KMEH), a wholly owned subsidiary of the company in Singapore for buyout of minority stake in Kaya Middle East FZC, subsidiary of KMEH situated at UAE.

Kaya reported net loss of Rs 2.71 crore in Q1 June 2017, lower than net loss of Rs 2.99 crore in Q1 June 2016. Net sales rose 5.39% to Rs 49.26 crore in Q1 June 2017 over Q1 June 2016.

Kaya is a pioneer in specialized skin care and delivers customized skin care services and products through a combination of qualified dermatologists and US-FDA approved cosmetic dermatological procedures across its chain of skin clinics in India & in Middle East through its step down subsidiary, Kaya Middle East FZE (KME).